Cadence Capital Management’s Medicines Co MDCO Stock Holding History

Cadence Capital Management’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-190,849	Closed	-$7.37M	–	689
2013 Q4	$7.37M	Sell	190,849 -142,814	-43%	-$5.11M	0.28%	103
2013 Q3	$11.2M	Buy	333,663 +36,364	+12%	+$1.16M	0.38%	54
2013 Q2	$9.14M	Buy	+297,299	New	+$9.95M	0.43%	103

Other funds holding MDCO

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Cadence Capital Management's MDCO Position: Q1 2014 in Review

Cadence Capital Management sold out of Medicines Co (MDCO) in Q1 2014, closing a stake of 190,849 shares — an estimated $7.37M sold.

Cadence Capital Management first reported a position in MDCO in Q2 2013 and held it in 3 quarters. The position peaked at $11.2M in Q3 2013. 166 funds tracked by Wall St. Rank hold MDCO as of Q1 2014.

Cadence Capital Management reported no remaining Medicines Co position as of Q1 2014 after selling out during the quarter.
Cadence Capital Management sold 190,849 Medicines Co shares in Q1 2014, an estimated $7.37M.
Cadence Capital Management first reported a position in Medicines Co in Q2 2013 and held it in 3 quarters.
Cadence Capital Management's Medicines Co position peaked at $11.2M in Q3 2013.
166 funds tracked by Wall St. Rank held Medicines Co as of Q1 2014.

Based on Cadence Capital Management's 13F filing for Q1 2014, filed 28 Apr 2014.